https://www.selleckchem.com/products/cynarin.html
OBJECTIVES Increasing antimicrobial resistance has renewed interest in older, less used antimicrobials. Cotrimoxazole shows promise; however hyperkalaemia and acute kidney injury (AKI) are potential complications. Identifying risk factors for, and quantification of, these events is required for safe-use. This study aims to evaluate predictors of cotrimoxazole-associated AKI and hyperkalaemia in a clinical setting. METHOD Patients prescribed cotrimoxazole were identified using electronic-healthcare records over three years (01/04/2016-31
처럼
논평
공유하다
